Shares of Imperva Inc (NYSE:IMPV) have been assigned an average rating of “Buy” from the twenty-three analysts that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation, eleven have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $51.23.

Several analysts have recently commented on the stock. Monness Crespi & Hardt upped their price objective on shares of Imperva from $55.00 to $57.00 and gave the company a “buy” rating in a report on Friday, July 28th. Evercore ISI set a $56.00 price objective on shares of Imperva and gave the company a “buy” rating in a report on Friday, July 28th. Piper Jaffray Companies set a $58.00 price objective on shares of Imperva and gave the company a “buy” rating in a report on Monday, August 28th. BidaskClub downgraded shares of Imperva from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 5th. Finally, Royal Bank Of Canada reaffirmed a “buy” rating and issued a $49.00 price objective on shares of Imperva in a report on Wednesday, October 18th.

In related news, Director Anthony J. Bettencourt sold 99,598 shares of the company’s stock in a transaction dated Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the completion of the sale, the director now owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 2.20% of the company’s stock.

Several institutional investors and hedge funds have recently made changes to their positions in IMPV. ETF Managers Group LLC purchased a new position in Imperva during the second quarter worth about $41,888,000. Clearbridge Investments LLC boosted its stake in Imperva by 47.0% during the first quarter. Clearbridge Investments LLC now owns 1,262,507 shares of the software maker’s stock worth $51,826,000 after buying an additional 403,809 shares during the period. BlackRock Inc. boosted its stake in Imperva by 11.3% during the second quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock worth $101,635,000 after buying an additional 215,170 shares during the period. Eagle Asset Management Inc. boosted its stake in Imperva by 17.7% during the second quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock worth $61,240,000 after buying an additional 192,625 shares during the period. Finally, Quantitative Investment Management LLC purchased a new position in Imperva during the second quarter worth about $8,546,000. 92.72% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Imperva Inc (IMPV) Given Average Rating of “Buy” by Brokerages” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this report on another site, it was stolen and reposted in violation of US and international trademark and copyright legislation. The legal version of this report can be viewed at https://www.americanbankingnews.com/2017/10/25/imperva-inc-impv-given-average-rating-of-buy-by-brokerages.html.

Shares of Imperva (NYSE IMPV) traded down 2.64% on Wednesday, reaching $42.35. 431,928 shares of the company were exchanged. Imperva has a 52 week low of $34.40 and a 52 week high of $52.40. The firm’s 50 day moving average price is $43.69 and its 200 day moving average price is $45.94. The stock’s market capitalization is $1.43 billion.

Imperva (NYSE:IMPV) last released its earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share for the quarter, missing the consensus estimate of $0.05 by ($0.15). The company had revenue of $74.44 million for the quarter, compared to analysts’ expectations of $74.30 million. Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm’s revenue for the quarter was up 28.6% on a year-over-year basis. During the same period in the prior year, the firm posted ($0.23) EPS. Equities research analysts anticipate that Imperva will post $0.85 EPS for the current year.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NYSE:IMPV)

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.